Olr223 inhibitors represent a unique class of chemical compounds that specifically target and modulate the activity of the Olr223 receptor, which is part of the olfactory receptor family in mammals. Olfactory receptors, including Olr223, are G-protein-coupled receptors (GPCRs) that play a significant role in the detection of odor molecules and the initiation of olfactory signal transduction pathways. These receptors are characterized by their seven transmembrane domains, which span the cell membrane and are responsible for transmitting extracellular signals to the intracellular environment. Olr223 inhibitors interact with the receptor by binding to specific sites, thereby preventing the activation of the receptor by its natural ligands. This inhibition can occur through competitive or non-competitive mechanisms, depending on the nature of the inhibitor and its binding affinity.
The study of Olr223 inhibitors is particularly relevant in the context of understanding olfactory signaling mechanisms and the broader GPCR signaling pathways. These inhibitors are often used as molecular tools to dissect the functional roles of Olr223 in various biological processes, especially those related to chemosensation and olfactory perception. By selectively inhibiting Olr223, researchers can explore the receptor's contributions to the detection and discrimination of odorants, as well as its involvement in more complex sensory processing. Additionally, Olr223 inhibitors provide insights into the structural dynamics of the receptor, helping to elucidate the conformational changes that occur upon ligand binding and inhibition. Understanding these molecular interactions at a detailed level is crucial for advancing knowledge in sensory biology, receptor-ligand interactions, and the intricate networks that govern signal transduction in olfactory systems.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING | 
|---|---|---|---|---|---|---|
| Lenvatinib | 417716-92-8 | sc-488530 sc-488530A sc-488530B | 5 mg 25 mg 100 mg | $178.00 $648.00 $1657.00 | 3 | |
| Multi-kinase inhibitor, potentially influences various pathways that regulate Olr223. | ||||||
| Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $28.00 $80.00 $412.00 $1860.00 $2962.00 | 5 | |
| MEK inhibitor, could indirectly impact Olr223 by modulating MEK/ERK signaling pathways. | ||||||